Noven Pharmaceuticals
Executive Summary
Files patent application for iontophoretic transdermal drug delivery system. The technology, which allows the incorporation of numerous drugs as well as a smaller surface area, pushes electrically charged and uncharged particles through the skin. Noven has a transdermal estrogen product in clinicals and plans to begin human testing of a transdermal nitroglycerine product "in the near future"....